Silverfin false false 28/02/2026 28/02/2026 06/02/2025 The principal activity of the Company during the financial period was specialist medical practice activities. Dr William Geoffrey Barton Singleton 06/02/2025 16234499 2026-02-28 16234499 bus:Director1 2026-02-28 16234499 core:CurrentFinancialInstruments 2026-02-28 16234499 2025-02-06 2026-02-28 16234499 bus:Micro-entities 2025-02-06 2026-02-28 16234499 bus:FilletedAccounts 2025-02-06 2026-02-28 16234499 bus:AuditExemptWithAccountantsReport 2025-02-06 2026-02-28 16234499 bus:PrivateLimitedCompanyLtd 2025-02-06 2026-02-28 16234499 bus:Director1 2025-02-06 2026-02-28 iso4217:GBP xbrli:pure

Company No: 16234499 (England and Wales)

WGBS NEUROSURGERY LIMITED

Unaudited Financial Statements
For the financial period from 06 February 2025 to 28 February 2026
Pages for filing with the registrar

WGBS NEUROSURGERY LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial period from 06 February 2025 to 28 February 2026

Contents

WGBS NEUROSURGERY LIMITED

BALANCE SHEET

As at 28 February 2026
WGBS NEUROSURGERY LIMITED

BALANCE SHEET (continued)

For the financial period from 06 February 2025 to 28 February 2026
28.02.2026
£
Fixed assets 1,269
Current assets 3,969
Creditors: amounts falling due within one year ( 667)
Net current assets 3,302
Total assets less current liabilities 4,571
Accruals and deferred income ( 1,440)
Net assets 3,131
Capital and reserves 3,131

For the financial period ending 28 February 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of WGBS Neurosurgery Limited (registered number: 16234499) were approved and authorised for issue by the director on 20 October 2026 and were signed on its behalf by:

Dr William Geoffrey Barton Singleton
Director
WGBS NEUROSURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 06 February 2025 to 28 February 2026
WGBS NEUROSURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial period from 06 February 2025 to 28 February 2026

1. Employees

Period from
06.02.2025 to
28.02.2026
Number
Monthly average number of persons employed by the Company during the financial period, including the director 1